Drug · DIN 02334402
NU-RISPERIDONE
No: cancelled
Cancelled by Health Canada because the company did not file its annual notification.
Status Cancelled (Unreturned Annual) since March 28, 2018.
- Drug Identification Number (DIN)
- 02334402
- Company (DIN owner)
- Nu-Pharm IncVaughan, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 2 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 4, 2009: NOC 10633Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named NU-RISPERIDONE
- DIN 02334372 · Cancelled (Unreturned Annual)
- DIN 02334380 · Cancelled (Unreturned Annual)
- DIN 02334399 · Cancelled (Unreturned Annual)
- DIN 02334410 · Cancelled (Unreturned Annual)
- DIN 02334429 · Cancelled (Unreturned Annual)